article

The diversity of synthetic biology applications

Posted: 23 September 2021 | | No comments yet

Synthetic biology processes can be useful to therapeutic development, diagnostics and vaccine advancement. Drug Target Review’s Victoria Rees spoke with Dr Jim Collins, Termeer Professor of Medical Engineering & Science at MIT and Founding Core Faculty & Lead, Living Cellular Devices at the Wyss Institute at Harvard University, to explore his research utilising synthetic biology and where he sees this field progressing in the future.

synthetic biology illustration

The field of synthetic biology encompasses both the design and construction of novel biological systems and the re-design of existing systems. While the concept has been around for over 20 years, this area of research is still revealing its full potential to those in the life sciences.

“Synthetic biology enables us to take an engineering approach to living cells and more broadly, biological material,” Collins began. “This provides us with capabilities to design and introduce novel functions and/or enhance existing functions.”












    To read this article in full, please complete the form below:

     









    This specialist content is provided to you free-of-charge thanks to the kind support of GenScript and Thermo Fisher Scientific

    By clicking submit you confirm that you accept our terms and conditions and privacy policy.

    Send this to a friend